Skip to main content
Contact Us
Subscribe
E-Edition
81°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Direxion Launches New Nanotechnology ETF, TYNE
November 23, 2021
Tickers
ALKS
ANGO
ARCT
BEAM
Tags
rafferty asset management
Nanotechnology
leveraged & inverse channel
From
ETF Trends
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
November 21, 2021
Tickers
CRSP
NTLA
Tags
Recent Press Releases
NTLA
Market News
From
Motley Fool
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
Biotech
VRTX
Benzinga
From
Benzinga
Intellia Therapeutics, Inc (NTLA) Q3 2021 Earnings Call Transcript
November 06, 2021
Tickers
NTLA
Tags
Market News
NTLA
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
FDA
IOVA
IBB
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
SGMO
DRNA
CORT
From
Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
Tickers
CRSP
NTLA
REGN
VRTX
Tags
Market News
NTLA
CRSP
From
Motley Fool
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
Tickers
ARKG
BEAM
DIS
EXAS
Tags
SNY
ARKG
PACB
From
Motley Fool
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
NTLA
NASDAQ:EDIT,NASDAQ:NTLA
Market News
From
InvestorPlace
EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock
October 18, 2021
Tickers
NTLA
Tags
News
NTLA
David Lebwohl
From
Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
Tickers
ARKG
ARKK
BEAM
CRSP
Tags
CRSP
ARKK
Market News
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
NTLA
CRSP
REGN
From
Motley Fool
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
October 15, 2021
Tickers
BLFS
EDIT
LZAGF
MRNA
Tags
NTLA
LZAGF
EDIT
From
Motley Fool
3 Top Breakout Stocks to Buy Right Now
October 15, 2021
Tickers
ALNY
CELH
GOOG
GOOGL
Tags
ALNY
GOOG
NTLA
From
Motley Fool
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
Tickers
ATRA
CRSP
CTSO
FIXX
Tags
News
RGLS
Earnings
From
Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
Tickers
CRSP
MRK
NTLA
REGN
Tags
Market News
SGEN
MRK
From
Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Tickers
AGRX
ALLO
CCXI
CLLS
Tags
Market News
Markets
ORIC
From
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Tickers
ABIO
ADVM
AFIB
AGRX
Tags
CYTK
HGEN
AMGN
From
Benzinga
3 Spooky Healthcare Stocks I Would Avoid in October
October 07, 2021
Tickers
BKD
EDIT
JNJ
MRNA
Tags
PFE
BKD
EDIT
From
Motley Fool
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
October 06, 2021
Tickers
NTLA
Tags
Phase 1 Trial
Health Care
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Tickers
AC
ACA
ACI
ADDYY
Tags
Analyst Ratings
COLM
UAA
From
Benzinga
3 Most Overvalued Biotech Stocks on the Market Right Now
October 01, 2021
Tickers
BEAM
BNTX
CRSP
CVAC
Tags
PFE
CRSP
NTLA
From
Motley Fool
Why Shares of Editas Medicine Are Lower This Morning
September 29, 2021
Tickers
EDIT
NTLA
REGN
Tags
Market News
NTLA
EDIT
From
Motley Fool
Breaking Down CRISPR Technology
September 28, 2021
Tickers
BEAM
CRBU
CRSP
EDIT
Tags
Market News
BEAM
NTLA
From
Motley Fool
Where Intellia Therapeutics Stands With Analysts
September 24, 2021
Tickers
NTLA
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
Tickers
ACHC
AEM
ALLO
ALV
Tags
ALLO
OSMT
Benzinga
From
Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
Tickers
ARKG
ARKK
BEAM
CLLS
Tags
ARKG
CRBU
EDIT
From
Motley Fool
3 Moonshot Stocks Hidden in Cathie Wood’s Portfolios
September 22, 2021
Tickers
AMZN
ARKK
CNDT
COIN
Tags
EGRNY
TSP
SKLZ
From
InvestorPlace
Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
September 16, 2021
Tickers
NTLA
Tags
gene therapy
Trading Ideas
Phase 1 Trial
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
Tickers
ACER
ACRS
AERI
CRVS
Tags
ACRS
PHIO
LPTX
From
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.